China SXT Pharmaceuticals
SXTC
SXTC
8 hedge funds and large institutions have $57K invested in China SXT Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$23.5K |
2 |
LFAS
2
Level Four Advisory Services
Dallas,
Texas
|
$5.26K |
3 |
HF
3
HRT Financial
New York
|
$5K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$3.67K |
5 |
TSS
5
Two Sigma Securities
New York
|
$6.15K |
Top Sellers
1 |
CAN
1
Cetera Advisor Networks
El Segundo,
California
|
$0 |
2 |
2
Renaissance Technologies
New York
|
$0 |